BCR-ABL plus acute myeloid leukemia: a rare and intriguing entity - a retrospective analysis of clinical and molecular features

被引：0
作者：
Neuendorff, N. R. [1 ]
Burmeister, T. [1 ,2 ]
Doerken, B. [1 ,2 ]
Westermann, J. [1 ,2 ]
机构：
[1] Charite, Klin Hamatol Onkol & Tumorimmunol, Campus Virchow Klinikum, Berlin, Germany
[2] Lab Berlin Charite Vivantes GmbH, Berlin, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V357
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] Spectrum of BCR-ABL Rearrangement Variants in Pakistani Patients with Chronic Myeloid Leukemia and Acute Lymphocytic Leukemia
    Ahmed, Z.
    Fatima, U.
    Ahmed, M.
    Qamber, A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05) : S21 - S22
  • [22] Characteristics of BCR-ABL rearrangement variants in Pakistani patients with chronic myeloid leukemia and acute lymphocytic leukemia
    Ahmed, Z. A.
    Nasir, A.
    Sheikh, M. S.
    Rizvi, A. Q.
    Moatter, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [23] The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia
    Bacher, Ulrike
    Schnittger, Susanne
    Kern, Wolfgang
    Hiddemann, Wolfgang
    Haferlach, Torsten
    Schoch, Claudia
    [J]. HAEMATOLOGICA, 2005, 90 (04) : 558 - 559
  • [24] BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador, South America
    Paz-y-Mino, C
    Burgos, R
    Morillo, SA
    Santos, JC
    Fiallo, BF
    Leone, PE
    [J]. CANCER GENETICS AND CYTOGENETICS, 2002, 132 (01) : 65 - 67
  • [25] SUSPENSION OF TREATMENT WITH BCR-ABL INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE
    Pastor Galan, I
    Correa, J. G.
    Senin, A.
    Diaz Gonzalez, A.
    Javier, K.
    Navarro, B.
    Bellosillo, B.
    Mora, E.
    Collado, R.
    Regadera, A.
    Carbonell, F.
    Cervantes, F.
    Alvarez Larran, A.
    Hernandez Boluda, J. C.
    [J]. HAEMATOLOGICA, 2017, 102 : 26 - 26
  • [26] Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia
    Kockan, Betul
    Toptas, Tayfur
    Atagunduz, Isik
    Tuglular, Ayse Tulin
    Ozer, Ayse
    Akkiprik, Mustafa
    [J]. ONCOLOGY LETTERS, 2018, 15 (02) : 2419 - 2424
  • [27] Clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    Nicolini, Franck
    [J]. HEMATOLOGIE, 2006, 12 (06): : 373 - 374
  • [28] The clinical outcomes of chronic myeloid leukemia patients harboring alternatively spliced BCR-ABL variants
    Ishida, Takashi
    Miyazaki, Koji
    Okina, Sosei
    Miyata, Tomomi
    Hayama, Kei
    Higashihara, Masaaki
    Suzuki, Takahiro
    [J]. HEMATOLOGY, 2019, 24 (01) : 49 - 51
  • [29] A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes
    桂晓敏
    [J]. China Medical Abstracts(Internal Medicine), 2014, 31 (02) : 122 - 123
  • [30] A CLINICAL AND LABORATORY STUDY OF CHRONIC MYELOID LEUKEMIA WITH ATYPICAL BCR-ABL FUSION GENE SUBTYPES
    Pan, J.
    Zhang, J.
    Chen, S.
    Sun, A.
    Wu, D.
    Qiu, H.
    [J]. HAEMATOLOGICA, 2014, 99 : 607 - 608
12345